Stay updated on ABP798 vs Rituximab in NHL: Clinical Trial
Sign up to get notified when there's something new on the ABP798 vs Rituximab in NHL: Clinical Trial page.

Latest updates to the ABP798 vs Rituximab in NHL: Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.3.1 was removed, indicating a minor site version update with no changes to the study information; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check17 days agoChange DetectedPublication attribution text was updated to indicate PubMed-derived publications are automatically filled and may not pertain to the study, and the revision tag was updated to v3.3.1.SummaryDifference0.1%

- Check24 days agoChange DetectedRemoved the government funding operating status notice from the page header. The notice previously informed users about potential delays in updates and responses due to appropriations.SummaryDifference0.2%

- Check38 days agoChange DetectedNo significant content changes detected on the Study Details page; core information such as the study title, interventions, eligibility criteria, outcomes, and locations remains the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check68 days agoChange DetectedUpdate to a newer revision identifier (v3.2.0) replaces the older v3.0.2.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page update is limited to updating the revision tag from v3.0.2 to v3.1.0; no substantive content changes are observed.SummaryDifference0.1%

Stay in the know with updates to ABP798 vs Rituximab in NHL: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABP798 vs Rituximab in NHL: Clinical Trial page.